Crestone, Inc
Clinical trials sponsored by Crestone, Inc, explained in plain language.
-
New antibiotic CRS3123 takes on c. diff in early trial
Disease control CompletedThis phase 2 study tested an experimental antibiotic called CRS3123 against the standard treatment vancomycin for Clostridioides difficile infection (C. diff). 43 adults with a first episode or first recurrence of C. diff took either CRS3123 or vancomycin for 10 days. The main go…
Phase: PHASE2 • Sponsor: Crestone, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Breakfast vs. pill: does food change how this drug works?
Knowledge-focused CompletedThis study looked at whether eating a high-fat meal changes how the body absorbs a single dose of the drug CRS3123. Seventeen healthy adults took the drug once after fasting and once after a high-fat meal. The goal was to see if food affects drug levels in the blood, which helps …
Phase: PHASE1 • Sponsor: Crestone, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC